15:19:58 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-08-29 Kvartalsrapport 2024-Q2
2024-06-06 Ordinarie utdelning CRNA 0.00 NOK
2024-06-05 Årsstämma 2024
2024-04-25 Bokslutskommuniké 2023
2023-10-04 Split CRNA 30:1
2023-08-24 Kvartalsrapport 2023-Q2
2023-05-22 Årsstämma 2023
2023-04-21 Ordinarie utdelning CRNA 0.00 NOK
2023-03-09 Extra Bolagsstämma 2023
2023-02-16 Bokslutskommuniké 2022
2022-11-03 Kvartalsrapport 2022-Q3
2022-08-18 Kvartalsrapport 2022-Q2
2022-05-12 Kvartalsrapport 2022-Q1
2022-04-20 Årsstämma 2022
2022-04-07 Ordinarie utdelning CRNA 0.00 NOK
2022-02-17 Bokslutskommuniké 2021
2021-11-25 Extra Bolagsstämma 2021
2021-11-04 Kvartalsrapport 2021-Q3
2021-08-18 Kvartalsrapport 2021-Q2
2021-05-06 Kvartalsrapport 2021-Q1
2021-03-18 Ordinarie utdelning CRNA 0.00 NOK
2021-03-17 Årsstämma 2021
2021-02-18 Bokslutskommuniké 2020
2020-11-05 Kvartalsrapport 2020-Q3
2020-08-20 Kvartalsrapport 2020-Q2
2020-05-07 Kvartalsrapport 2020-Q1
2020-04-30 Ordinarie utdelning CRNA 0.00 NOK
2020-04-29 Årsstämma 2020
2020-03-11 Bokslutskommuniké 2019
2019-11-07 Kvartalsrapport 2019-Q3
2019-08-22 Kvartalsrapport 2019-Q2
2019-05-09 Kvartalsrapport 2019-Q1
2019-04-10 Ordinarie utdelning CRNA 0.00 NOK
2019-04-09 Årsstämma 2019
2019-02-14 Bokslutskommuniké 2018
2018-11-01 Kvartalsrapport 2018-Q3
2018-08-23 Kvartalsrapport 2018-Q2
2018-05-03 Kvartalsrapport 2018-Q1
2018-04-12 Ordinarie utdelning CRNA 0.00 NOK
2018-04-11 Årsstämma 2018
2018-02-15 Bokslutskommuniké 2017
2017-11-16 Kvartalsrapport 2017-Q3
2017-08-24 Kvartalsrapport 2017-Q2
2017-04-25 Kvartalsrapport 2017-Q1
2017-04-05 Årsstämma 2017
2017-02-16 Bokslutskommuniké 2016
2016-11-17 Kvartalsrapport 2016-Q3
2016-08-25 Kvartalsrapport 2016-Q2
2016-05-12 Kvartalsrapport 2016-Q1
2016-04-14 Ordinarie utdelning CRNA 0.00 NOK
2016-04-13 Årsstämma 2016
2015-06-23 Ordinarie utdelning CRNA 0.00 NOK
2015-06-22 Årsstämma 2015

Beskrivning

LandNorge
ListaOB Match
SektorHälsovård
IndustriBioteknik
Circio Holding är ett läkemedelsbolag. Bolaget specialistkompetens återfinns inom riktad immunterapi som används vid behandling av cancerpatienter. Bolagets verksamhet består av forskning och utveckling och läkemedlen säljs idag under separata varumärken. Ett flertal partnerskap på marknaden har ingåtts för att stärka samarbetet inom utvecklingen av ny immunterapi. Bolaget grundades 2010 och har sitt huvudkontor i Lysaker.
2023-03-02 13:24:58

Oslo, 2 March 2023: Reference is made to Targovax ASA's ("Targovax" or the "Company") stock exchange announcement published on 2 March 2023, regarding the board of directors' resolution to increase the Company's share capital with NOK 10,378.90 by the issuance of 103,789 new shares, each with a nominal value of NOK 0.10, in order to facilitate an exercise of 103,789 RSUs pursuant to the Company's RSU program for Board members.

  • Primary insider, Diane Mellett, member of the board of directors, has exercised 20,870 restrictive stock units ("RSUs") under her RSU agreement and subscribed for 20,870 new shares in the Company following the exercise of RSUs. The exercise price for the options was NOK 0.10 per new share.
  • Primary insider, Robert Burns, member of the board of directors, has exercised 23,307 restrictive stock units ("RSUs") under his RSU agreement and subscribed for 23,307 new shares in the Company following the exercise of RSUs. The exercise price for the options was NOK 0.10 per new share.
  • Primary insider, Damian Marron, member of the board of directors, has exercised 55,588 restrictive stock units ("RSUs") under his RSU agreement and subscribed for 55,588 new shares in the Company following the exercise of RSUs. The exercise price for the options was NOK 0.10 per new share.
  • Primary insider, Eva-Lotta Allan, member of the board of directors, has exercised 4,024 restrictive stock units ("RSUs") under her RSU agreement and subscribed for 4,024 new shares in the Company following the exercise of RSUs. The exercise price for the options was NOK 0.10 per new share.
Following the RSU exercise and subscription of new shares and the registration of the share capital increase pertaining to the new shares with the Norwegian Register of Business Enterprises (Nw. Foretaksregisteret), the above mentioned primary insiders holds the following:
  • Diane Mellett holds 122,948 shares, 104,388 RSUs and nil options in Targovax.
  • Robert Burns holds 298,761 shares, 43,071 RSUs and nil options in Targovax.
  • Damian Marron holds 55,588 shares, 97,765 RSUs and nil options in Targovax.
  • Eva-Lotta Allan holds 98,883 shares, 64,469 RSUs and nil options in Targovax.

Please refer to the attached notification of trading for further details.

Notification by Primary Insiders 02.03.23.docx.pdf (https://mb.cision.com/Public/17093/3726627/8ed179f09261c940.pdf)